Slide 1: Optomed Q2 2025
Optomed Q2 2025 7th August 2025 Juho Himberg, CEO Sakari Knuutti, CFO
Slide 2: Highlights Q2
Highlights Q2 1. 2. 3. 11.2 % currency- Devices segment Optomed Lumo was adjusted revenue continued its strong launched growth momentum with currency adjusted growth of 36.1%
Slide 3: Capturing Health
Capturing Health • Adapts to various healthcare settings from primary care and large-scale eye screenings to emergency room diagnostics and pediatric retinal examinations • The device brings effective eye screening and oculomics capabilities with high-quality optics and integrated AI for immediate a
Slide 4: Q2-2025 Key Figures
Q2-2025 Key Figures WE CONTINUED THE GOOD TREND SINCE Q4-2024 WITH 11.2 % CURRENCY-ADJUSTED GROWTH Q2/2025 Q2/2024 Change Revenue 3,845 3,505 9.7% Gross profit 2,496 2,450 1.9% Gross margin 64.9% 69.9% -50pps EBITDA -921 -1,185 22.3% EBITDA margin -23.9% -33.8% - Net profit / loss -1,644 -1,793 8.3%
Slide 5: H1-2025 Key Figures
H1-2025 Key Figures CURRENCY-ADJUSTED REVENUE GROWTH WAS 15.5 PERCENT DURING H1 H1/2025 H1/2024 Change Revenue 7,866 6,832 15.1% Gross profit 5,190 4,663 11.3% Gross margin 66.0% 68.3% -23pps EBITDA -1,658 -1,833 9.6% EBITDA margin -21.1% -26.8% - Net profit / loss -3,225 -2,883 -11.8% Earnings per
Slide 6: Segment highlights
Segment highlights OPT@MED
Slide 7: Devices Segment Q2-2025
Devices Segment Q2-2025 ANOTHER SOLID QUARTER FOR DEVICES WITH 36.1 % GROWTH ON CURRENCY ADJUSTED BASIS Q2/2025 Q2/2024 Change Revenue growth continued 1. strong Revenue 1,409 1,073 31.3% Aurora AEYE continues to scale Gross profit 806 695 16.0% 2. steadily in both adoption and usage Gross margin 57
Slide 8: Software Segment Q2-2025
Software Segment Q2-2025 THE SOFTWARE SEGMENT CONTINUED WITH ITS STEADY CONTRIBUTION Q2/2025 Q2/2024 Change Healthcare business continued its 1. momentum from Q1 and the revenue increased Revenue 2,435 2,432 0.1% Gross profit 1,690 1,746 -3.2% Non-healthcare consulting revenue 2. declined during the
Slide 9: Cash Flow Q2-2025
Cash Flow Q2-2025 CASH POSITION AT EUR 7.1 MILLION Q2 2025 Q2 2024 Loss for the financial year -1,644 -1,793 • Cash flows before change Cash flows before change -730 -688 in net working capital in net working capital on the same level as during the comparison period Change in net working capital -88
Slide 10: Outlook 2025
Outlook 2025 Outlook 2025: Key items supporting our growth: • Increased adoption of AI-powered screening solutions, particularly in the Optomed expects its full U.S. following the FDA clearance year 2025 revenue to grow • New partnerships and collaborations with healthcare providers and strongly com
Slide 11: Summary
Summary • Strong performance continued especially in the Devices segment • Aurora AEYE continues to scale steadily in both adoption and usage • Optomed Lumo was launched • Optomed expects its full year 2025 revenue to grow strongly compared to 2024
Slide 12: Appendix
Appendix OPT@MED
Slide 13: Devices Segment H1-2025
Devices Segment H1-2025 SOLID FIRST HALF FOR THE DEVICES SEGMENT H1/2025 H1/2024 Change 1. Revenue grew 49.5 % Revenue 2,935 1,963 49.5% Gross profit 1,704 1,211 40.7% 2. EBITDA increased 46.8% Gross margin 58.0 % 61.7 % -37pps EBITDA -557 -1,047 46.8% EBITDA margin -19.0 % -53.3 % +343pps
Slide 14: Software Segment H1-2025
Software Segment H1-2025 THE SOFTWARE SEGMENT CONTINUED WITH ITS STEADY CONTRIBUTION IN H1 H1/2025 H1/2024 Change 1. Revenue grew 1.3 % Revenue 4,931 4,869 1.3% Gross profit 3,486 3,442 1.3% 2. EBITDA decreased 10.8% Gross margin 70.7 % 70.7 % 0pps EBITDA 875 982 -10.8% EBITDA margin 17.8 % 20.2 % -
Slide 15: Cash Flow H1-2025
Cash Flow H1-2025 H1 2025 H1 2024 • Cash flows before change Loss for the financial year -3,225 -2,883 in net working capital EUR - Cash flows before change -1,422 -1,283 1.4 million in net working capital Change in net working capital 184 296 • Cash position at EUR 7.1 million Cash flows before fin
Slide 16: Balance Sheet
Balance Sheet 30 June 2025 30 June 2024 • Equity ratio of 74.9 (74.9) ASSETS percent Goodwill 4,256 4,256 Development costs 8,687 8,126 • Total borrowings of EUR Other intangible assets 1,244 1,586 1.8 (2.9) million Total intangible assets 14,187 13,969 Total tangible assets 783 630 • Net working ca